{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:08:46Z","timestamp":1790424526956,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.11.036","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T15:21:17Z","timestamp":1671031277000},"page":"684-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study"],"prefix":"10.1016","volume":"41","author":[{"given":"Donal","family":"Bisanzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Talbird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Van Effelterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Gaudig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie Oriol","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita J.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2022.11.036_b0005","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"Feldmann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.11.036_b0010","unstructured":"Centers of Disease Control and Prevention. History of Ebola Virus Disease (EVD) Outbreaks; September 15, 2022. <https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html> [accessed October 12, 2022]."},{"issue":"suppl_5","key":"10.1016\/j.vaccine.2022.11.036_b0015","doi-asserted-by":"crossref","first-page":"S698","DOI":"10.1093\/infdis\/jiy213","article-title":"The economic and social burden of the 2014 Ebola outbreak in West Africa","volume":"218","author":"Huber","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.036_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.puhe.2016.10.020","article-title":"The health impact of the 2014\u201315 Ebola outbreak","volume":"143","author":"Elston","year":"2017","journal-title":"Public Health"},{"issue":"10174","key":"10.1016\/j.vaccine.2022.11.036_b0025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.036_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15585\/mmwr.su6503a3","article-title":"CDC\u2019s response to the 2014\u20132016 Ebola epidemic\u2014Guinea, Liberia, and Sierra Leone","volume":"65","author":"Dahl","year":"2016","journal-title":"MMWR Suppl"},{"issue":"20","key":"10.1016\/j.vaccine.2022.11.036_b0035","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1073\/pnas.1817329116","article-title":"Ebola vaccination in the democratic republic of the congo","volume":"116","author":"Wells","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.11.036_b0040","unstructured":"World Health Organization. 10th Ebola outbreak in the Democratic Republic of the Congo declared over; vigilance against flare-ups and support for survivors must continue; June 25, 2020a. <https:\/\/www.who.int\/news-room\/detail\/25-06-2020-10th-ebola-outbreak-in-the-democratic-republic-of-the-congo-declared-over-vigilance-against-flare-ups-and-support-for-survivors-must-continue> [accessed June 26, 2020]."},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.036_b0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(20)30476-X","article-title":"Safety and immunogenicity of a two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial","volume":"21","author":"Pollard","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.036_b0050","unstructured":"Reuters. Rollout of Johnson & Johnson Ebola vaccine begins in Congo; November 2019. <https:\/\/www.reuters.com\/article\/us-health-ebola-congo-vaccine-idUSKBN1XO1LP> [accessed April 29, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0055","unstructured":"Rwanda Biomedical Centre. Combating Ebola; 2021. <https:\/\/rbc.gov.rw\/index.php?id=724> [accessed April 29, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0060","unstructured":"European Medicine Agency (EMA). Mvabea: EPAR \u2013 Product information; 2020a July 23. <https:\/\/www.ema.europa.eu\/documents\/product-information\/mvabea-epar-product-information_en.pdf> [accessed April 29, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0065","unstructured":"European Medicine Agency (EMA). Zabdeno: EPAR \u2013 Product information; 2020b July 23. <https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zabdeno-epar-product-information_en.pdf> [accessed April 29, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0070","unstructured":"World Health Organization. Prequalified vaccines; 2021a. <https:\/\/extranet.who.int\/pqweb\/vaccines\/prequalified-vaccines?field_vaccines_effective_date%5Bdate%5D=&field_vaccines_effective_date_1%5Bdate%5D=&field_vaccines_type%5B%5D=Ebola+vaccine+%28Ad26.ZEBOV-GP+%5Brecombinant%5D%29&field_vaccines_type%5B%5D=Ebola+vaccine+%28MVA-BN-Filo+%5Brecombinant%5D%29&field_vaccines_name=&search_api_views_fulltext=&field_vaccines_number_of_doses=> [accessed June 25, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0075","unstructured":"World Health Organization. Cote d\u2019Ivoire declares first Ebola outbreak in more than 25 years; August 14, 2021b. <https:\/\/www.afro.who.int\/news\/cote-divoire-declares-first-ebola-outbreak-more-25-years> [accessed September 14, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0080","unstructured":"World Health Organization. Ebola outbreak 2021 \u2013 N\u2019Zerekore, Guinea; 2021c. <https:\/\/www.who.int\/emergencies\/situations\/ebola-2021-nzerekore-guinea>."},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.036_b0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/22221751.2020.1722036","article-title":"Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks","volume":"9","author":"Matson","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.036_b0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3201\/eid2201.151410","article-title":"Effectiveness of ring vaccination as control strategy for Ebola virus disease","volume":"22","author":"Kucharski","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2022.11.036_b0095","doi-asserted-by":"crossref","first-page":"e0005093","DOI":"10.1371\/journal.pntd.0005093","article-title":"Containing Ebola at the source with ring vaccination","volume":"10","author":"Merler","year":"2016","journal-title":"PLOS Negl Trop Dis"},{"issue":"10216","key":"10.1016\/j.vaccine.2022.11.036_b0100","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0140-6736(19)32532-2","article-title":"Ebola response and community engagement: how to build a bridge?","volume":"394","author":"Ntumba","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2022.11.036_b0105","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/infdis\/jiaa163","article-title":"The impact of different types of violence on Ebola virus transmission during the 2018\u20132020 outbreak in the Democratic Republic of the Congo","volume":"222","author":"Kelly","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.036_b0110","unstructured":"World Health Organization. Ebola virus disease: vaccines; January 2020b. <https:\/\/www.who.int\/news-room\/q-a-detail\/ebola-vaccines> [accessed April 29, 2021]."},{"key":"10.1016\/j.vaccine.2022.11.036_b0115","unstructured":"World Health Organization. Weekly Epidemiological Record (WER).4 June 2021, vol. 96, No. 22 (pp. 197\u2013216) [EN\/FR]. <https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/341623\/WER9622-eng-fre.pdf?sequence=1&isAllowed=y>."},{"issue":"9996","key":"10.1016\/j.vaccine.2022.11.036_b0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.11.036_b0125","unstructured":"The Strategic Advisory Group of Experts (SAGE). Releve epidemiologique hebdomadaire\/weekly epidemiological record. Summary of the April 2017 meeting of the Strategic Advisory Group of Experts on Immunization; 25-27 April 2017; Geneva, Switzerland."},{"issue":"27","key":"10.1016\/j.vaccine.2022.11.036_b0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.epidem.2019.03.001","article-title":"Control of Ebola virus disease outbreaks: comparison of health care worker-targeted and community vaccination strategies","volume":"1","author":"Robert","year":"2019","journal-title":"Epidemics"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.036_b0135","doi-asserted-by":"crossref","first-page":"e0230406","DOI":"10.1371\/journal.pone.0230406","article-title":"Impact of prophylactic vaccination strategies on Ebola virus transmission: a modeling analysis","volume":"15","author":"Potluri","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2022.11.036_b0140","article-title":"Modeling the 2014 Ebola virus epidemic\u2013agent-based simulations, temporal analysis and future predictions for Liberia and Sierra Leone","volume":"7","author":"Siettos","year":"2015","journal-title":"PLoS Curr."},{"issue":"7","key":"10.1016\/j.vaccine.2022.11.036_b0145","doi-asserted-by":"crossref","first-page":"e0254044","DOI":"10.1371\/journal.pone.0254044","article-title":"A hybrid simulation model to study the impact of combined interventions on Ebola epidemic","volume":"16","author":"Chen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2022.11.036_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.epidem.2017.02.010","article-title":"Using data-driven agent-based models for forecasting emerging infectious diseases","volume":"22","author":"Venkatramanan","year":"2018","journal-title":"Epidemics"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.036_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-09564-4","article-title":"Analysis of individual-level data from 2018\u20132020 Ebola outbreak in Democratic Republic of the Congo","volume":"12","author":"Vossler","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.036_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-022-02232-4","article-title":"Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia","volume":"20","author":"Bisanzio","year":"2022","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.036_b0165","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1016\/S2666-5247(22)00183-5","article-title":"Projected burden and duration of the 2022 Monkeypox outbreaks in non-endemic countries","volume":"3","author":"Bisanzio","year":"2022","journal-title":"Lancet Microbe"},{"issue":"8","key":"10.1016\/j.vaccine.2022.11.036_b0170","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3201\/eid2208.160163","article-title":"Exposure-specific and age-specific attack rates for Ebola virus disease in Ebola-affected households","volume":"22","author":"Bower","year":"2016","journal-title":"Sierra Leone Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.036_b0175","series-title":"Analyzing social networks","author":"Borgatti","year":"2018"},{"key":"10.1016\/j.vaccine.2022.11.036_b0180","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/j.ijid.2010.06.020","article-title":"Super-spreaders in infectious diseases","volume":"15","author":"Stein","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.036_b0185","doi-asserted-by":"crossref","unstructured":"Kleinberg J. The small-world phenomenon: an algorithmic perspective. In: Proceedings of the 32nd ACM symposium on theory of computing; 21\u201323 May 2000; Portland, Oregon. p. 163\u201370.","DOI":"10.1145\/335305.335325"},{"key":"10.1016\/j.vaccine.2022.11.036_b0190","doi-asserted-by":"crossref","first-page":"20150279","DOI":"10.1098\/rsif.2015.0279","article-title":"The role of heterogeneity in contact timing and duration in network models of influenza spread in schools","volume":"12","author":"Toth","year":"2015","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2022.11.036_b0195","doi-asserted-by":"crossref","first-page":"e1005697","DOI":"10.1371\/journal.pcbi.1005697","article-title":"Projecting social contact matrices in 152 countries using contact surveys and demographic data","volume":"13","author":"Prem","year":"2017","journal-title":"PLOS Comput Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.036_b0200","first-page":"130","article-title":"Contact tracing during an outbreak of Ebola virus disease in the Western area districts of Sierra Leone: lessons for future Ebola outbreak response","volume":"22","author":"Olu","year":"2016","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.036_b0205","doi-asserted-by":"crossref","first-page":"e0005597","DOI":"10.1371\/journal.pntd.0005597","article-title":"Ebola virus disease contact tracing activities, lessons learned and best practices during the Duport Road outbreak in Monrovia, Liberia, November 2015","volume":"11","author":"Wolfe","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2022.11.036_b0210","doi-asserted-by":"crossref","first-page":"160294","DOI":"10.1098\/rsos.160294","article-title":"Spatial spread of the West Africa Ebola epidemic","volume":"3","author":"Kramer","year":"2016","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.vaccine.2022.11.036_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-41192-3","article-title":"Utilizing general human movement models to predict the spread of emerging infectious diseases in resource poor settings","volume":"9","author":"Kraemer","year":"2019","journal-title":"Sci Rep"},{"issue":"50","key":"10.1016\/j.vaccine.2022.11.036_b0220","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.15585\/mmwr.mm6850a3","article-title":"Ebola virus disease outbreak\u2014Democratic Republic of the Congo, August 2018\u2013November 2019","volume":"68","author":"Aruna","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2022.11.036_b0225","doi-asserted-by":"crossref","first-page":"e0007814","DOI":"10.1371\/journal.pntd.0007814","article-title":"Vaccination strategies to control Ebola epidemics in the context of variable household inaccessibility levels","volume":"13","author":"Chowell","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"10068","key":"10.1016\/j.vaccine.2022.11.036_b0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.vaccine.2022.11.036_b0235","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2019.03.004","article-title":"Ebola epidemic in war-torn Democratic Republic of Congo, 2018: acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus-Zaire Ebolavirus Vaccine","volume":"37","author":"Kasereka","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.11.036_b0240","series-title":"Strategic response plan for the Ebola Virus Disease outbreak in the provinces of north Kivu and Ituri","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.vaccine.2022.11.036_b0245","series-title":"Bootstrap Methods and Their Application, Chapter 5","author":"Davison","year":"1997"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.036_b0250","first-page":"6","article-title":"An introduction to the bootstrap with applications in R","volume":"13","author":"Davison","year":"2002","journal-title":"Stat Comput Stat Graph Newslett"},{"key":"10.1016\/j.vaccine.2022.11.036_b0255","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1080\/03610926.2017.1388397","article-title":"Estimation of Sobol\u2019s sensitivity indices under generalized linear models","volume":"47","author":"Lu","year":"2018","journal-title":"Commun Stat Theory Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.036_b0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.11648\/j.cajph.20200601.13","article-title":"Challenges in implementation of infection prevention and control measures during the tenth Ebola virus disease in Northeastern of DRC, in 2019","volume":"6","author":"Mankadi","year":"2020","journal-title":"Central African J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.036_b0265","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41591-021-01313-w","article-title":"The need for a new strategy for Ebola vaccination","volume":"27","author":"Bausch","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.11.036_b0270","unstructured":"Ebola J&J vaccination campaign launched jointly by Rwanda and Democratic Republic of Congo. Reliefweb; December 10, 2019. <https:\/\/reliefweb.int\/report\/rwanda\/ebola-jj-vaccination-campaign-launched-jointly-rwanda-and-democratic-republic-congo>."},{"key":"10.1016\/j.vaccine.2022.11.036_b0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12916-015-0477-2","article-title":"Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control","volume":"13","author":"Coltart","year":"2015","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.036_b0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3934\/mbe.2018015","article-title":"The potential impact of a prophylactic vaccine for Ebola in Sierra Leone","volume":"15","author":"Bodine","year":"2018","journal-title":"Math Biosci Eng"},{"key":"10.1016\/j.vaccine.2022.11.036_b0285","series-title":"Regional Ebola preparedness overview of needs and requirements","author":"World Health Organization","year":"2019"},{"issue":"11","key":"10.1016\/j.vaccine.2022.11.036_b0290","doi-asserted-by":"crossref","first-page":"e0007814","DOI":"10.1371\/journal.pntd.0007814","article-title":"Vaccination strategies to control Ebola epidemics in the context of variable household inaccessibility levels","volume":"13","author":"Chowell","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.036_b0295","unstructured":"World Health Organization, Regional Office for Africa. Contact tracing during an outbreak of Ebola virus disease; 2014. <https:\/\/www.who.int\/csr\/resources\/publications\/ebola\/contact-tracing-during-outbreak-of-ebola.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22014499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22014499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:20:36Z","timestamp":1759404036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22014499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22014499"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}